Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Oct 13, 2026

PALI — Palisade Bio, Inc. Dilution Risk Tracker

Track PALI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PALI — Get alerts when the score changes →

As of October 13, 2026, Palisade Bio, Inc. (PALI) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. Palisade Bio, Inc. has a market capitalization of $277.09M, 174.27M shares outstanding, 98 institutional holders tracked. Stored dilution-related fields include 51.66M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
37
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 24%
📜 Warrant Exercise model 40%
• Significant warrants: 30% of shares outstanding
• Elevated warrant risk score (70/100)
🔄 Reverse Split model est. 15%
• 52-week low $0.53 has breached $1
🔔 Track PALI — Get forecast alerts →

Market Data

Market Cap$277.09M
Shares Outstanding174.27M
Float128.36M
Cash$130.17M
Debt$87.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore40/100DilutionWatch score record
Shares Outstanding174.27MVerified float table or market cache
Public Float128.36MVerified float table or market cache
Market Cap$277.09MMarket data cache
Cash Runway120.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants51.66MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 25.5% shares (2026Q1 vs prior)
98 institutional holders · 172.98M shares
#1 JANUS HENDERSON GROUP PLC 21.38M shares
#2 PERCEPTIVE ADVISORS LLC 17.86M shares
#3 B Group, Inc. 11.41M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest31.02M
Days to Cover6.1
% of Float24.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-10
xbrl XBRL CONVERTIBLE 2016-03-14
8-K 8K EVENT 2026-04-02
4 INSIDER TRANSACTION 2026-02-13
4 INSIDER TRANSACTION 2026-02-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PALI Dilution Snapshot

Palisade Bio, Inc. (PALI) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PALI's DilutionScore is currently 40/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 30/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202640/100MEDIUM14 days
Sep 27 – Sep 29, 202630/100MEDIUM3 days
Aug 22 – Sep 26, 202635/100MEDIUM36 days
Aug 14 – Aug 21, 202639/100MEDIUM7 days
Jul 16 – Aug 13, 202635/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PALI shares outstanding have increased 16.5% from 149.00M (Mar 2026) to 173.58M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 2026173.58M128.36M▲ 4.64%
Apr 09, 2026167.42M122.67M▲ 0.33%
Mar 27, 2026165.88M122.27M▲ 4.21%
Mar 22, 2026149.00M117.33M▲ 11.33%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PALI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PALI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PALI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PALI
PALI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.